Prevention of non-melanoma skin cancer.

被引:24
|
作者
Stratton S.P. [1 ]
机构
[1] Section of Hematology and Oncology, Arizona Cancer Center, College of Medicine, University of Arizona, Tucson, 85724, AZ
基金
美国国家卫生研究院;
关键词
Squamous Cell Carcinoma; Celecoxib; Skin Cancer; EGCG; Basal Cell Carcinoma;
D O I
10.1007/s11912-001-0080-x
中图分类号
学科分类号
摘要
Basal cell and squamous cell carcinomas comprise the majority of non-melanoma skin cancers. Whereas the incidence of skin cancer is equivalent to that of all other cancers combined, non-melanoma skin cancer receives a disproportionate share of attention because mortality is relatively low. However, the impact on public health is striking. This review is intended to update readers on the current findings in research on the prevention of these diseases. Topics covered include preventive strategies targeting high-risk populations, chemoprevention (including treatment of intraepithelial neoplasia), and an overview of recent and ongoing clinical and preclinical studies involving new chemopreventive agents.
引用
收藏
页码:295 / 300
页数:5
相关论文
共 50 条
  • [31] Non-Melanoma Skin Cancer - Overview
    Joseph, Kurian
    CURRENT CANCER THERAPY REVIEWS, 2016, 12 (03) : 142 - 151
  • [32] NON-MELANOMA SKIN CANCER Introduction
    Rohrer, Thomas E.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2011, 30 (01) : 1 - 2
  • [33] NON-MELANOMA SKIN-CANCER
    PICKLES, T
    BRITISH MEDICAL JOURNAL, 1989, 299 (6713): : 1464 - 1464
  • [34] Immunotherapy for Non-melanoma Skin Cancer
    Shalhout, Sophia Z.
    Emerick, Kevin S.
    Kaufman, Howard L.
    Miller, David M.
    CURRENT ONCOLOGY REPORTS, 2021, 23 (11)
  • [35] Occupational non-melanoma skin cancer
    Lei, U
    Masmas, TN
    Frentz, G
    ACTA DERMATO-VENEREOLOGICA, 2001, 81 (06) : 415 - 417
  • [36] The Occurrence of Non-Melanoma Skin Cancer Predicts Risk of Subsequent Solid Organ Cancer.
    McDonald, S.
    Carroll, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 97 - 98
  • [37] High-dose-rate brachytherapy in the treatment of non-melanoma skin cancer.
    Gonzalez Ruiz, M. A.
    Quiros Rivero, J.
    Cruz Munoz, M. C.
    Cabrera Rodriguez, J. J.
    Munoz Garcia, J. L.
    Rios Kavadoy, Y.
    Ropero Carmona, M. F.
    Corbacho Campos, A.
    Garcia Urra, F.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : E581 - E581
  • [38] Interstitial brachytherapy in non-melanoma skin cancer. Results of an expert center.
    Antelo-Redondo, G.
    Gonzalez Vigueras, J.
    Fernandez de Manzanos, I. Visus
    Najjari Jamal, D.
    Slocker Escarpa, A.
    Perez Montero, H.
    Linares Galiano, I.
    Gracia Lucio, R.
    Guedea Edo, F.
    Gutierrez Miguelez, C.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S1101 - S1102
  • [39] Cost and patterns of care among patients with advanced non-melanoma skin cancer.
    Byfield, S. DaCosta
    Chen, D. M.
    Ramanan, D. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Telomerase activity in melanoma and non-melanoma skin cancer
    Parris, CN
    Jezzard, S
    Silver, A
    MacKie, R
    McGregor, JM
    Newbold, RF
    BRITISH JOURNAL OF CANCER, 1999, 79 (01) : 47 - 53